SCHEMBL14048147

SCHEMBL14048147

COc1ccc(S(=O)(=O)Nc2cccc(Cl)c2C)cc1S(=O)(=O)Cl

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 3/20 0.55
▸ MAPK1 P28482 2/20 0.55
▸ MEN1 O00255 2/20 0.55
▸ LMNA P02545 2/20 0.54
▸ SMN1; SMN2 Q16637 1/20 0.54
▸ MAPT P10636 1/20 0.50
▸ ALDH1A1 P00352 5/20 0.49
▸ HTT P42858 2/20 0.49
▸ TP53 P04637 2/20 0.49
▸ TSHR P16473 3/20 0.48
▸ NPC1 O15118 1/20 0.48
▸ PKM P14618 2/20 0.47
▸ CYP1A2 P05177 1/20 0.47
▸ CYP3A4 P08684 1/20 0.47
▸ CYP2C19 P33261 1/20 0.47
▸ KEAP1 Q14145 1/20 0.47
▸ NFE2L2 Q16236 1/20 0.47
▸ USP2 O75604 1/20 0.46
▸ RAB9A P51151 1/20 0.46
▸ NPSR1 Q6W5P4 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14048137 0.93 KMT2A (0.57) KMT2AMAPK1MEN1LMNASMN1; SMN2
SCHEMBL14048146 0.84 KMT2A (0.56) KMT2AMAPK1MEN1LMNASMN1; SMN2
SCHEMBL29562355 0.82 MAPT (0.63) KMT2AMAPK1MEN1LMNASMN1; SMN2
SCHEMBL29562518 0.82 MAPT (0.63) KMT2AMAPK1MEN1LMNASMN1; SMN2
SCHEMBL22095975 0.77 PKM (0.61) KMT2AMAPK1MEN1SMN1; SMN2MAPT
SCHEMBL6187346 0.76 HTR6 (0.74) —
SCHEMBL22095984 0.76 LMNA (0.58) KMT2AMAPK1MEN1LMNASMN1; SMN2
SCHEMBL29561286 0.76 MAPT (0.55) KMT2AMEN1LMNASMN1; SMN2MAPT
Hydrochloric Acid SCHEMBL6188378 0.76 HTR6 (0.73) —
SCHEMBL2176669 0.75 LMNA (0.61) KMT2AMEN1LMNASMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008129288-A2 DISULFONAMIDES USEFUL IN THE TREATMENT OF INFLAMMATION BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2008-10-30 — — WO disclosed
Send feedback